Cargando…

Salivary cytokine panel indicative of non-small cell lung cancer

OBJECTIVE: To develop a combinatorial panel of salivary cytokines that manifests the presence of non-small cell lung cancer (NSCLC) that will eventually improve prognosis by facilitating the early diagnosis and management of this common cancer. METHODS: We performed a case-control study comparing sa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koizumi, Tomonobu, Shetty, Vivek, Yamaguchi, Masaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Clinical Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136026/ https://www.ncbi.nlm.nih.gov/pubmed/29916282 http://dx.doi.org/10.1177/0300060518775563

Ejemplares similares

Plasma cytokine levels and the presence of colorectal cancer
por: Yamaguchi, Masaki, et al.
Publicado: (2019)

Impact of short-term storage of plasma samples on quantitation of ultra-low levels of interleukin-6
por: Yamaguchi, Masaki, et al.
Publicado: (2021)

Response to lorlatinib on a patient with ALK‐rearranged non‐small cell lung cancer harboring 1151Tins mutation with uterine metastasis
por: Kobayashi, Takashi, et al.
Publicado: (2021)

Protein expression profiles indicative for drug resistance of non-small cell lung cancer
por: Volm, M, et al.
Publicado: (2002)

Automated-immunosensor with centrifugal fluid valves for salivary cortisol measurement
por: Yamaguchi, Masaki, et al.
Publicado: (2014)

Relationship between salivary cortisol and depression in adolescent survivors of a major natural disaster
por: Yonekura, Takashi, et al.
Publicado: (2014)

Solid component tumor doubling time is a prognostic factor in non-small cell lung cancer patients
por: Miura, Kentaro, et al.
Publicado: (2019)

Syndrome of Inappropriate Antidiuretic Hormone Secretion as the Initial Presentation in a Patient with Stage I Small-cell Lung Cancer
por: Koizumi, Tomonobu, et al.
Publicado: (2022)

Role of cytokines in combinatorial immunotherapeutics of non‐small cell lung cancer through systems perspective
por: Misra, Pragya, et al.
Publicado: (2019)

Alectinib-Induced Alopecia in a Patient with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer
por: Koizumi, Tomonobu, et al.
Publicado: (2016)

Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer
por: Pinato, D J, et al.
Publicado: (2014)

Stress Evaluation in Adult Patients with Atopic Dermatitis Using Salivary Cortisol
por: Mizawa, Megumi, et al.
Publicado: (2013)

Clinical Experience of Bronchoscopy-Guided Radiofrequency Ablation for Peripheral-Type Lung Cancer
por: Koizumi, Tomonobu, et al.
Publicado: (2013)

Phase 1 study of lenvatinib combined with carboplatin and paclitaxel in patients with non-small-cell lung cancer
por: Nishio, M, et al.
Publicado: (2013)

Clinical utility of the C‐reactive protein:albumin ratio in non‐small cell lung cancer patients treated with nivolumab
por: Araki, Taisuke, et al.
Publicado: (2021)

Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer
por: Zhu, Bojin, et al.
Publicado: (2018)

Supportive care in patients with advanced non-small-cell lung cancer
por: Di Maio, M, et al.
Publicado: (2003)

Comparing Gene Panels for Non-Retinal Indications: A Systematic Review
por: Procopio, Rebecca, et al.
Publicado: (2023)

Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non‐small cell lung cancer
por: Wakabayashi, Yu, et al.
Publicado: (2020)

Observation of hepatotoxicity during long-term gefitinib administration in patients with non-small-cell lung cancer
por: Wang, Jingjing, et al.
Publicado: (2016)

Cytokine Release Syndrome Induced by Immune-checkpoint Inhibitor Therapy for Non-small-cell Lung Cancer
por: Yomota, Makiko, et al.
Publicado: (2021)

Hyperprogressive disease in patients with non‐small cell lung cancer treated with nivolumab: A case series
por: Kanazu, Masaki, et al.
Publicado: (2018)

Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer
por: Cortes, J, et al.
Publicado: (2002)

Clinical Validation of a Protein Biomarker Panel for Non-Small Cell Lung Cancer
por: Jung, Young Ju, et al.
Publicado: (2018)

A tumor-associated autoantibody panel for the detection of non-small cell lung cancer
por: Cai, Ruijun, et al.
Publicado: (2022)

Identification of exosome protein panels as predictive biomarkers for non-small cell lung cancer
por: Luo, Bin, et al.
Publicado: (2023)

Lobectomy versus Sublobar Resection in Non-Lepidic Small-Sized Non-Small Cell Lung Cancer
por: Namkoong, Min, et al.
Publicado: (2017)

Lung adenocarcinoma initially presenting as Trousseau's syndrome treated successfully with pembrolizumab: A case report
por: Nakano, Yuta, et al.
Publicado: (2020)

Salivary Lipids of Patients with Non-Small Cell Lung Cancer Show Perturbation with Respect to Plasma
por: Hwang, Bo Young, et al.
Publicado: (2023)

Clinical significance of plasma free DNA in patients with non-small cell lung cancer
por: Ma, Lanxiang, et al.
Publicado: (2019)

Differential expression of hypoxia-inducible factor 1α in non-small cell lung cancer and small cell lung cancer
por: Karetsi, Eleni, et al.
Publicado: (2012)

Surgical outcomes in patients with small cell lung cancer: comparative analysis of computed tomograpy-detected patients with others
por: Koizumi, Tomonobu, et al.
Publicado: (2013)

Current Surgical Indications for Non-Small-Cell Lung Cancer
por: Deboever, Nathaniel, et al.
Publicado: (2022)

Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer
por: Di Maio, M, et al.
Publicado: (2004)

Disposable Collection Kit for Rapid and Reliable Collection of Saliva
por: Yamaguchi, Masaki, et al.
Publicado: (2015)

Spontaneous regressions in non-small cell lung cancer with different clinical outcomes
por: Yamamoto, Masaki, et al.
Publicado: (2022)

Cytokine Panels and Pediatric Acute Respiratory Distress Syndrome: A Translational Investigation*
por: McKeone, Daniel J., et al.
Publicado: (2020)

Evaluation of 29 indicators for the prognosis of advanced non-small cell lung cancer with cytokine-induced killer cell therapy combined with chemotherapy
por: JIA, HEJIN, et al.
Publicado: (2016)

Clinical analysis of EGFR‐positive non‐small cell lung cancer patients treated with first‐line afatinib: A Nagano Lung Cancer Research Group
por: Sonehara, Kei, et al.
Publicado: (2019)

Treatment of Non-Small-Cell Lung Cancer with Erlotinib following Gefitinib-Induced Hepatotoxicity: Review of 8 Clinical Cases
por: Yano, Yukihiro, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ul68e389l62rk03i1tc3cjjpnv